Zydus Lifesciences Limited - Company Profile

Q: Who are the current directors of Zydus Lifesciences Limited?

The current directors of Zydus Lifesciences Limited are Ganesh Narayan Nayak, Shelina Pranav Parikh, Pankaj Ramanbhai Patel, Sharvil Pankajbhai Patel, Mukesh Mangalbhai Patel, Monappa Arun Akhil, Apurva Shishir Diwanji, Bhadresh Kantilal Shah, Upasana Konidela, Dhaval Narendra Soni, Tushar Dhansukh Shroff.

It is a pharma public limited company based in Ahmedabad, Gujarat, India, established in 1995.

1995 Ahmedabad, Gujarat, India Active

Last Updated: December 19, 2025

Access Report

About Zydus Lifesciences Limited

Zydus Lifesciences Limited, a active public limited company, was established on 15 May 1995 in Ahmedabad, Gujarat, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: L24230GJ1995PLC025878. Registered under ROC Roc Ahmedabad. it is listed on BSE: 532321 and NSE: CADILAHC. It has an authorized capital of ₹172.50 Cr and a paid-up capital of ₹100.62 Cr.

Formerly known as Cadila Healthcare Private Limited. It upholds a compliant status. In 2023, it reported revenue of ₹9,280.00 Cr and a net worth of ₹13,639.42 Cr. Employing 13,762 professional, Its leadership includes Ganesh Narayan Nayak (Whole-Time Director), Shelina Pranav Parikh (Director), Pankaj Ramanbhai Patel (Director). Past directors included Dharmishta Narendraprasad Raval, Upenkumar Shah Harshadlal, Pranlal Bhogilal Patel. It holds ₹1,500.00 Cr open charges and ₹3,001.83 Cr settled loans. Its latest AGM occurred on 12 August 2025, with the balance sheet filed on 31 March 2025. It is based at Zydus Corporate Park,Scheme No. 63, Survey No. 536 Khoraj(Gandhinagar),Nr. Vaishnodevi Circ, Le,, Ahmedabad, Gujarat, 382481.

Company Details

CIN/LLPIN
L24230GJ1995PLC025878
Registration Number
025878
Incorporation Date
15 May 1995
Authorized Capital
₹172.50 Cr
Paid-Up Capital
₹100.62 Cr
ROC Code
Roc Ahmedabad
Listing Status
Listed (BSE: 532321, NSE: CADILAHC)
Company Status
Active

Key Metrics

Authorised Capital ₹ 172.50 Cr as on 19-12-2025
Paid Up Capital ₹ 100.62 Cr as on 19-12-2025
Company Age 30 Year, 8 Months
Last Filing with ROC 31 Mar 2025
Open Charges ₹ 1,500.00 Cr as on 19-12-2025
Satisfied Charges ₹ 3,001.83 Cr as on 19-12-2025
Revenue Growth **** 13.72% (FY 2023)
Profit Growth **** 78.25% (FY 2023)
Ebitda **** 27.96% (FY 2023)
Net Worth 3.01% (FY 2023)
Total Assets **** 15.92% (FY 2023)

Comprehensive Company Insights

Explore comprehensive insights into Zydus Lifesciences Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Zydus Lifesciences Limited?

Current Directors

Name	Designation	Appointment Date	Status
Ganesh Narayan Nayak	Whole-Time Director	12 Jul 2017	Current
Shelina Pranav Parikh	Director	17 May 2024	Current
Pankaj Ramanbhai Patel	Director	15 May 1995	Current
Sharvil Pankajbhai Patel	Managing Director	01 Aug 1997	Current
Mukesh Mangalbhai Patel	Director	01 Aug 1997	Current
Monappa Arun Akhil	Director	29 Nov 2022	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Additional Director	30 Jul 2014	Past
Pramod Abcsdd	Company Secretary	07 Feb 2019	Past
Pramod Abcsdd	Director	12 Jan 2011	Past
Pramod Abcsdd	Additional Director	19 Jul 2011	Past
Pramod Abcsdd	Person Incharge	05 Mar 2014	Past
Pramod Abcsdd	Additional Director	08 Aug 2024	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Zydus Lifesciences.

Zydus Lifesciences Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 13.72% increase. The company also saw a substantial improvement in profitability, with a 78.25% increase in profit. The company's net worth moved up by a moderate rise of 3.01%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

13.72%

*******

Revenue from Operations

*******

9.39%

*******

Total Assets

*******

15.92%

*******

Profit or Loss

*******

78.25%

*******

Net Worth

*******

3.01%

*******

EBITDA

*******

27.96%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Zydus Lifesciences?

In 2024, Zydus Lifesciences had a promoter holding of 74.98% and a public holding of 25.01%. The company had 16 Subsidiaries and 3 Joint Ventures. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹15,000,000,000.00

Satisfied Charges

₹30,018,316,836.00

Charges Breakdown by Lending Institutions

Others : 1500.00 Cr

Latest Charge Details

Date	Lender	Amount	Status
21 Dec 2012	Others	₹1,500.00 Cr	Open
24 Dec 2015	Citi Bank N.A.	₹225.00 Cr	Satisfied
07 Aug 2014	Citi Bank N.A.	₹93.00 Cr	Satisfied
28 May 2014	Others	₹120.40 Cr	Satisfied
21 Nov 2013	Citi Bank N.A.	₹94.50 Cr	Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Zydus Lifesciences?

Zydus Lifesciences has a workforce of 13762 employees as of Jan 16, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Zydus Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Zydus Lifesciences's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Zydus Lifesciences

Recent Activity within the Organization

Director Appointment

Progress on Tushar Dhansukh Shroff was appointed as a Cfo was appointed as a Cfo on 16 Sep 2025 & has been associated with this company since 4 months 18 days . was documented.
16 Sep 2025
Annual General Meeting

Progress on Zydus Lifesciences Limited last Annual general meeting of members was held on 12 Aug 2025 as per latest MCA records. was documented.
12 Aug 2025
Balance Sheet

Zydus Lifesciences Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad. was recorded as a recent event.
31 Mar 2025
Director Appointment

Progress on Shelina Pranav Parikh was appointed as a Director was appointed as a Director on 17 May 2024 & has been associated with this company since 1 year 8 months . was documented.
17 May 2024
Director Appointment

The activity Monappa Arun Akhil was appointed as a Director was appointed as a Director on 29 Nov 2022 & has been associated with this company since 3 years 2 months . was completed.
29 Nov 2022
Director Appointment

Upasana Konidela was appointed as a Director was appointed as a Director on 29 Nov 2022 & has been associated with this company since 3 years 2 months . was recorded as a recent event.
29 Nov 2022

Explore recent activity and updates - View Recent Activity